|
Financial Daily from THE HINDU group of publications Friday, October 12, 2001 |
||
|
|
||
|
AGRI-BUSINESS CORPORATE INDUSTRY MACRO ECONOMY MARKETS NEWS OPINION INFO-TECH CATALYST INVESTMENT WORLD MONEY & BANKING LOGISTICS |
Markets
| Next
| Prev
GlaxoSmithKline - VRS is no big deal
GLAXOSMITHKLINE'S decision to go ahead with a VRS programme for about 622 employees in unlikely to have an immediate impact on its share price. The VRS is in keeping with the company's desire to eliminate superfluous cost, but a change in its valuation c
an come about only when its sales show signs of picking up. - BL Research Bureau
|
|
|
Related links: Glaxo SmithKline offers VRS for Worli unit workers Comment on this article to BLFeedback@thehindu.co.in Send this article to Friends by E-Mail
Next: Hind Oil - No open offer implication Prev: HDFC: Strong, sound investments Markets Agri-Business | Corporate | Industry | Macro Economy | Markets | News | Opinion | Info-Tech | Catalyst | Investment World | Money & Banking | Logistics | Copyright © 2001 The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line. |